Reliability of average daily steps measured through a consumer smartwatch in Parkinson’s disease phenotypes, stages and severities: a cross-sectional study. (Preprint)

Author:

Bianchini EdoardoORCID,Rinaldi Domiziana,De Carolis Lanfranco,Galli Silvia,Alborghetti Marika,Hansen Clint,Suppa Antonio,Salvetti Marco,Pontieri Francesco Ernesto,Vuillerme NicolasORCID

Abstract

BACKGROUND

Average daily steps (avDS) could be a valuable indicator of real-world ambulation in people with Parkinson’s disease (PwPD) and previous studies reported the validity and reliability of this measure. Nonetheless, no study to date has considered disease phenotype, stage and severity when assessing reliability of consumer wrist-worn devices to estimate daily step count in unsupervised, free-living conditions in PwPD.

OBJECTIVE

To assess and compare the reliability of a consumer wrist-worn smartwatch (Garmin Vivosmart 4) in counting avDS in PwPD in unsupervised, free-living conditions among disease phenotypes, stages, and severity groups.

METHODS

One-hundred-four PwPD were monitored through Garmin Vivosmart 4 for 5 consecutive days. Total daily steps for each day were recorded and avDS were calculated. PwPD were dichotomized into tremor dominant (TD) (N=39) or postural instability and gait disorder (PIGD) (N=65), presence (N=57) or absence (N=47) of tremor, and mild (N=65) or moderate (N=39) disease severity. Based on modified Hoeh and Yahr scale (mHY), PwPD were further dichotomized into earlier (mHY 1-2) (N=68) or intermediate (mHY 2.5-3) (N=36) disease stage. Intraclass correlation coefficient (ICC) (3, k), standard error of measurement (SEM) and minimum detectable change (MDC) were used to evaluate the reliability of avDS for each subgroup. The threshold for acceptability was set at an ICC ≥ 0.8 with a lower bound of 95% confidence interval (CI) ≥ 0.75. Student’s t-tests for independent groups and analysis of 83.4% CI overlap were used to compare ICC between each group pair.

RESULTS

Reliability of avDS measured through Garmin Vivosmart 4 for 5 consecutive days in unsupervised, free-living conditions was acceptable in the overall population with an ICC of 0.89 (0.85-0.92), SEM% below 10% and an MDC of 1580 steps/day (27% of criterion). In all investigated subgroups, reliability of avDS was also acceptable (ICC range 0.84-0.94). However, ICCs were significantly lower in PwPD with tremor (P=.030), with mild severity (P=.040) and earlier stage (P=.003). Moreover, SEM% was below 10% in PwPD with PIGD phenotype, without tremor, moderate disease severity and intermediate disease stage, with a MDC ranging from 1148 to 1687 steps/day (18-25% of criterion). Conversely, in PwPD with TD phenotype, tremor, mild disease severity and earlier disease stage, SEM was >10% of criterion and MDC values ranged from 1401 to 2263 steps/day (30- 33% of the criterion).

CONCLUSIONS

In mild-to-moderate PwPD, avDS measured through a consumer smartwatch in unsupervised, free-living conditions for 5 consecutive days are reliable irrespective of disease phenotype, stage, and severity. However, in PwPD with TD phenotype, tremor, mild disease severity and earlier disease stages, reliability could be lower. These findings could facilitate a broader and informed implementation of avDS as an index of ambulatory activity in PwPD.

Publisher

JMIR Publications Inc.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3